Insulin signaling to hepatic lipid metabolism in health and disease

References

• Abe H, Yamada N, Kamata K, Kuwaki T, Shimada M, Osuga J, Shionoiri F, Yahagi N, Kadowaki T, Tamemoto H, Ishibashi S, Yazaki Y, Makuuchi M. 1998. Hypertension, hypertriglyceridemia, and impaired endothelium-dependent vascular relaxation in mice lacking insulin receptor substrate-1. J Clin Invest 101:1784–1788.
   PubMed Web of Science ®Google Scholar
• Adeli K, Taghibiglou C, Van Iderstine SC, Lewis GF. 2001. Mechanisms of hepatic very low-density lipoprotein overproduction in insulin resistance. Trends Cardiovasc Med 11:170–176.
   PubMed Web of Science ®Google Scholar
• Alessi DR, James SR, Downes CP, Holmes AB, Gaffney PR, Reese CB, Cohen P. 1997. Characterization of a 3-phosphoinositide-dependent protein kinase which phosphorylates and activates protein kinase Balpha. Curr Biol 7:261–269.
   PubMed Web of Science ®Google Scholar
• Altomonte J, Cong L, Harbaran S, Richter A, Xu J, Meseck M, Dong HH. 2004. Foxo1 mediates insulin action on apoC-III and triglyceride metabolism. J Clin Invest 114:1493–1503.
   PubMed Web of Science ®Google Scholar
• Anderson N, Borlak J. 2008. Molecular mechanisms and therapeutic targets in steatosis and steatohepatitis. Pharmacol Rev 60:311–357.
   PubMed Web of Science ®Google Scholar
• Angulo P, Lindor KD. 2002. Non-alcoholic fatty liver disease. J Gastroenterol Hepatol 17 Suppl:S186–S190.
   PubMed Web of Science ®Google Scholar
• Araki E, Lipes MA, Patti ME, Brüning JC, Haag B 3rd, Johnson RS, Kahn CR. 1994. Alternative pathway of insulin signalling in mice with targeted disruption of the IRS-1 gene. Nature 372:186–190.
   PubMed Web of Science ®Google Scholar
• Azain MJ, Fukuda N, Chao FF, Yamamoto M, Ontko JA. 1985. Contributions of fatty acid and sterol synthesis to triglyceride and cholesterol secretion by the perfused rat liver in genetic hyperlipemia and obesity. J Biol Chem 260:174–181.
   PubMed Web of Science ®Google Scholar
• Bécard D, Hainault I, Azzout-Marniche D, Bertry-Coussot L, Ferré P, Foufelle F. 2001. Adenovirus-mediated overexpression of sterol regulatory element binding protein-1c mimics insulin effects on hepatic gene expression and glucose homeostasis in diabetic mice. Diabetes 50:2425–2430.
   PubMedGoogle Scholar
• Bengoechea-Alonso MT, Ericsson J. 2009. A phosphorylation cascade controls the degradation of active SREBP1. J Biol Chem 284:5885–5895.
   PubMed Web of Science ®Google Scholar
• Bergman RN. 2000. Non-esterified fatty acids and the liver: why is insulin secreted into the portal vein? Diabetologia 43:946–952.
   Google Scholar
• Biddinger SB, Hernandez-Ono A, Rask-Madsen C, Haas JT, Alemán JO, Suzuki R, Scapa EF, Agarwal C, Carey MC, Stephanopoulos G, Cohen DE, King GL, Ginsberg HN, Kahn CR. 2008. Hepatic insulin resistance is sufficient to produce dyslipidemia and susceptibility to atherosclerosis. Cell Metab 7:125–134.
   PubMed Web of Science ®Google Scholar
• Boyko EJ. 2010. ACCORD glycemia results continue to puzzle. Diabetes Care 33:1149–1150.
   Google Scholar
• Bozulic L, Hemmings BA. 2009. PIKKing on PKB: regulation of PKB activity by phosphorylation. Curr Opin Cell Biol 21:256–261.
   PubMed Web of Science ®Google Scholar
• Brown MS, Goldstein JL. 2008. Selective versus total insulin resistance: a pathogenic paradox. Cell Metab 7:95–96.
   PubMed Web of Science ®Google Scholar
• Brown NF, Stefanovic-Racic M, Sipula IJ, Perdomo G. 2007. The mammalian target of rapamycin regulates lipid metabolism in primary cultures of rat hepatocytes. Metab Clin Exp 56:1500–1507.
   PubMed Web of Science ®Google Scholar
• Browning JD, Horton JD. 2004. Molecular mediators of hepatic steatosis and liver injury. J Clin Invest 114:147–152.
   PubMed Web of Science ®Google Scholar
• Brunet A, Bonni A, Zigmond MJ, Lin MZ, Juo P, Hu LS, Anderson MJ, Arden KC, Blenis J, Greenberg ME. 1999. Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell 96:857–868.
   PubMed Web of Science ®Google Scholar
• Burgess SC, Iizuka K, Jeoung NH, Harris RA, Kashiwaya Y, Veech RL, Kitazume T, Uyeda K. 2008. Carbohydrate-response element-binding protein deletion alters substrate utilization producing an energy-deficient liver. J Biol Chem 283:1670–1678.
   PubMed Web of Science ®Google Scholar
• Carpentier A, Taghibiglou C, Leung N, Szeto L, Van Iderstine SC, Uffelman KD, Buckingham R, Adeli K, Lewis GF. 2002. Ameliorated hepatic insulin resistance is associated with normalization of microsomal triglyceride transfer protein expression and reduction in very low density lipoprotein assembly and secretion in the fructose-fed hamster. J Biol Chem 277:28795–28802.
   PubMed Web of Science ®Google Scholar
• Chen WS, Xu PZ, Gottlob K, Chen ML, Sokol K, Shiyanova T, Roninson I, Weng W, Suzuki R, Tobe K, Kadowaki T, Hay N. 2001. Growth retardation and increased apoptosis in mice with homozygous disruption of the Akt1 gene. Genes Dev 15:2203–2208.
   PubMed Web of Science ®Google Scholar
• Chirieac DV, Chirieac LR, Corsetti JP, Cianci J, Sparks CE, Sparks JD. 2000. Glucose-stimulated insulin secretion suppresses hepatic triglyceride-rich lipoprotein and apoB production. Am J Physiol Endocrinol Metab 279:E1003–E1011.
   Google Scholar
• Chirieac DV, Davidson NO, Sparks CE, Sparks JD. 2006. PI3-kinase activity modulates apo B available for hepatic VLDL production in apobec-1−/- mice. Am J Physiol Gastrointest Liver Physiol 291:G382–G388.
   Google Scholar
• Cho H, Mu J, Kim JK, Thorvaldsen JL, Chu Q, Crenshaw EB 3rd, Kaestner KH, Bartolomei MS, Shulman GI, Birnbaum MJ. 2001a. Insulin resistance and a diabetes mellitus-like syndrome in mice lacking the protein kinase Akt2 (PKB beta). Science 292:1728–1731.
   PubMed Web of Science ®Google Scholar
• Cho H, Thorvaldsen JL, Chu Q, Feng F, Birnbaum MJ. 2001b. Akt1/PKBalpha is required for normal growth but dispensable for maintenance of glucose homeostasis in mice. J Biol Chem 276:38349–38352.
   PubMed Web of Science ®Google Scholar
• Cohen P, Miyazaki M, Socci ND, Hagge-Greenberg A, Liedtke W, Soukas AA, Sharma R, Hudgins LC, Ntambi JM, Friedman JM. 2002. Role for stearoyl-CoA desaturase-1 in leptin-mediated weight loss. Science 297:240–243.
   PubMed Web of Science ®Google Scholar
• Cross DA, Alessi DR, Cohen P, Andjelkovich M, Hemmings BA. 1995. Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B. Nature 378:785–789.
   PubMed Web of Science ®Google Scholar
• Dentin R, Benhamed F, Hainault I, Fauveau V, Foufelle F, Dyck JR, Girard J, Postic C. 2006. Liver-specific inhibition of ChREBP improves hepatic steatosis and insulin resistance in ob/ob mice. Diabetes 55:2159–2170.
   PubMed Web of Science ®Google Scholar
• Dentin R, Liu Y, Koo SH, Hedrick S, Vargas T, Heredia J, Yates J 3rd, Montminy M. 2007. Insulin modulates gluconeogenesis by inhibition of the coactivator TORC2. Nature 449:366–369.
   PubMed Web of Science ®Google Scholar
• Dentin R, Pégorier JP, Benhamed F, Foufelle F, Ferré P, Fauveau V, Magnuson MA, Girard J, Postic C. 2004. Hepatic glucokinase is required for the synergistic action of ChREBP and SREBP-1c on glycolytic and lipogenic gene expression. J Biol Chem 279:20314–20326.
   PubMed Web of Science ®Google Scholar
• Diraison F, Beylot M. 1998. Role of human liver lipogenesis and reesterification in triglycerides secretion and in FFA reesterification. Am J Physiol 274:E321–E327.
   PubMed Web of Science ®Google Scholar
• Diraison F, Dusserre E, Vidal H, Sothier M, Beylot M. 2002. Increased hepatic lipogenesis but decreased expression of lipogenic gene in adipose tissue in human obesity. Am J Physiol Endocrinol Metab 282:E46–E51.
   PubMed Web of Science ®Google Scholar
• Diraison F, Moulin P, Beylot M. 2003. Contribution of hepatic de novo lipogenesis and reesterification of plasma non-esterified fatty acids to plasma triglyceride synthesis during non-alcoholic fatty liver disease. Diabetes Metab 29:478–485.
   PubMed Web of Science ®Google Scholar
• Dong XC, Copps KD, Guo S, Li Y, Kollipara R, DePinho RA, White MF. 2008. Inactivation of hepatic Foxo1 by insulin signaling is required for adaptive nutrient homeostasis and endocrine growth regulation. Cell Metab 8:65–76.
   PubMed Web of Science ®Google Scholar
• Donnelly KL, Smith CI, Schwarzenberg SJ, Jessurun J, Boldt MD, Parks EJ. 2005. Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease. J Clin Invest 115:1343–1351.
   PubMed Web of Science ®Google Scholar
• Düvel K, Yecies JL, Menon S, Raman P, Lipovsky AI, Souza AL, Triantafellow E, Ma Q, Gorski R, Cleaver S, Vander Heiden MG, MacKeigan JP, Finan PM, Clish CB, Murphy LO, Manning BD. 2010. Activation of a metabolic gene regulatory network downstream of mTOR complex 1. Mol Cell 39:171–183.
   PubMed Web of Science ®Google Scholar
• Easton RM, Cho H, Roovers K, Shineman DW, Mizrahi M, Forman MS, Lee VM, Szabolcs M, de Jong R, Oltersdorf T, Ludwig T, Efstratiadis A, Birnbaum MJ. 2005. Role for Akt3/protein kinase Bgamma in attainment of normal brain size. Mol Cell Biol 25:1869–1878.
   PubMed Web of Science ®Google Scholar
• Estall JL, Kahn M, Cooper MP, Fisher FM, Wu MK, Laznik D, Qu L, Cohen DE, Shulman GI, Spiegelman BM. 2009. Sensitivity of lipid metabolism and insulin signaling to genetic alterations in hepatic peroxisome proliferator-activated receptor-gamma coactivator-1alpha expression. Diabetes 58:1499–1508.
   PubMed Web of Science ®Google Scholar
• Fabbrini E, Magkos F, Mohammed BS, Pietka T, Abumrad NA, Patterson BW, Okunade A, Klein S. 2009. Intrahepatic fat, not visceral fat, is linked with metabolic complications of obesity. Proc Natl Acad Sci USA 106:15430–15435.
   PubMed Web of Science ®Google Scholar
• Fabbrini E, Sullivan S, Klein S. 2010. Obesity and nonalcoholic fatty liver disease: biochemical, metabolic, and clinical implications. Hepatology 51:679–689.
   PubMed Web of Science ®Google Scholar
• Fleischmann M, Iynedjian PB. 2000. Regulation of sterol regulatory-element binding protein 1 gene expression in liver: role of insulin and protein kinase B/cAkt. Biochem J 349:13–17.
   PubMed Web of Science ®Google Scholar
• Forcheron F, Cachefo A, Thevenon S, Pinteur C, Beylot M. 2002. Mechanisms of the triglyceride- and cholesterol-lowering effect of fenofibrate in hyperlipidemic type 2 diabetic patients. Diabetes 51:3486–3491.
   Google Scholar
• Foretz M, Guichard C, Ferré P, Foufelle F. 1999. Sterol regulatory element binding protein-1c is a major mediator of insulin action on the hepatic expression of glucokinase and lipogenesis-related genes. Proc Natl Acad Sci USA 96:12737–12742.
   PubMed Web of Science ®Google Scholar
• Foster KG, Fingar DC. 2010. Mammalian target of rapamycin (mTOR): conducting the cellular signaling symphony. J Biol Chem 285:14071–14077.
   PubMed Web of Science ®Google Scholar
• Garofalo RS, Orena SJ, Rafidi K, Torchia AJ, Stock JL, Hildebrandt AL, Coskran T, Black SC, Brees DJ, Wicks JR, McNeish JD, Coleman KG. 2003. Severe diabetes, age-dependent loss of adipose tissue, and mild growth deficiency in mice lacking Akt2/PKB beta. J Clin Invest 112:197–208.
   PubMed Web of Science ®Google Scholar
• Ginsberg HN, Zhang YL, Hernandez-Ono A. 2005. Regulation of plasma triglycerides in insulin resistance and diabetes. Arch Med Res 36:232–240.
   PubMed Web of Science ®Google Scholar
• Gross DN, van den Heuvel AP, Birnbaum MJ. 2008. The role of FoxO in the regulation of metabolism. Oncogene 27:2320–2336.
   PubMed Web of Science ®Google Scholar
• Guo S, Copps KD, Dong X, Park S, Cheng Z, Pocai A, Rossetti L, Sajan M, Farese RV, White MF. 2009. The Irs1 branch of the insulin signaling cascade plays a dominant role in hepatic nutrient homeostasis. Mol Cell Biol 29:5070–5083.
   PubMed Web of Science ®Google Scholar
• Gutiérrez-Juárez R, Pocai A, Mulas C, Ono H, Bhanot S, Monia BP, Rossetti L. 2006. Critical role of stearoyl-CoA desaturase-1 (SCD1) in the onset of diet-induced hepatic insulin resistance. J Clin Invest 116:1686–1695.
   PubMed Web of Science ®Google Scholar
• Han S, Liang CP, Westerterp M, Senokuchi T, Welch CL, Wang Q, Matsumoto M, Accili D, Tall AR. 2009. Hepatic insulin signaling regulates VLDL secretion and atherogenesis in mice. J Clin Invest 119:1029–1041.
   PubMed Web of Science ®Google Scholar
• Hanada M, Feng J, Hemmings BA. 2004. Structure, regulation and function of PKB/AKT–a major therapeutic target. Biochim Biophys Acta 1697:3–16.
   PubMed Web of Science ®Google Scholar
• Harada N, Oda Z, Hara Y, Fujinami K, Okawa M, Ohbuchi K, Yonemoto M, Ikeda Y, Ohwaki K, Aragane K, Tamai Y, Kusunoki J. 2007. Hepatic de novo lipogenesis is present in liver-specific ACC1-deficient mice. Mol Cell Biol 27:1881–1888.
   PubMed Web of Science ®Google Scholar
• He L, Hou X, Kanel G, Zeng N, Galicia V, Wang Y, Yang J, Wu H, Birnbaum MJ, Stiles BL. 2010. The critical role of AKT2 in hepatic steatosis induced by PTEN loss. Am J Pathol 176:2302–2308.
   PubMed Web of Science ®Google Scholar
• He L, Sabet A, Djedjos S, Miller R, Sun X, Hussain MA, Radovick S, Wondisford FE. 2009. Metformin and insulin suppress hepatic gluconeogenesis through phosphorylation of CREB binding protein. Cell 137:635–646.
   PubMed Web of Science ®Google Scholar
• Hegarty BD, Bobard A, Hainault I, Ferré P, Bossard P, Foufelle F. 2005. Distinct roles of insulin and liver X receptor in the induction and cleavage of sterol regulatory element-binding protein-1c. Proc Natl Acad Sci USA 102:791–796.
   PubMedGoogle Scholar
• Hillgartner FB, Salati LM, Goodridge AG. 1995. Physiological and molecular mechanisms involved in nutritional regulation of fatty acid synthesis. Physiol Rev 75:47–76.
   PubMed Web of Science ®Google Scholar
• Horie Y, Suzuki A, Kataoka E, Sasaki T, Hamada K, Sasaki J, Mizuno K, Hasegawa G, Kishimoto H, Iizuka M, Naito M, Enomoto K, Watanabe S, Mak TW, Nakano T. 2004. Hepatocyte-specific Pten deficiency results in steatohepatitis and hepatocellular carcinomas. J Clin Invest 113:1774–1783.
   PubMed Web of Science ®Google Scholar
• Horton JD. 2002. Sterol regulatory element-binding proteins: transcriptional activators of lipid synthesis. Biochem Soc Trans 30:1091–1095.
   PubMed Web of Science ®Google Scholar
• Horton JD, Bashmakov Y, Shimomura I, Shimano H. 1998a. Regulation of sterol regulatory element binding proteins in livers of fasted and refed mice. Proc Natl Acad Sci USA 95:5987–5992.
   PubMed Web of Science ®Google Scholar
• Horton JD, Shimomura I, Brown MS, Hammer RE, Goldstein JL, Shimano H. 1998b. Activation of cholesterol synthesis in preference to fatty acid synthesis in liver and adipose tissue of transgenic mice overproducing sterol regulatory element-binding protein-2. J Clin Invest 101:2331–2339.
   PubMed Web of Science ®Google Scholar
• Hresko RC, Mueckler M. 2005. mTOR.RICTOR is the Ser473 kinase for Akt/protein kinase B in 3T3-L1 adipocytes. J Biol Chem 280:40406–40416.
   PubMed Web of Science ®Google Scholar
• Iizuka K, Bruick RK, Liang G, Horton JD, Uyeda K. 2004. Deficiency of carbohydrate response element-binding protein (ChREBP) reduces lipogenesis as well as glycolysis. Proc Natl Acad Sci USA 101:7281–7286.
   PubMed Web of Science ®Google Scholar
• Iizuka K, Miller B, Uyeda K. 2006. Deficiency of carbohydrate-activated transcription factor ChREBP prevents obesity and improves plasma glucose control in leptin-deficient (ob/ob) mice. Am J Physiol Endocrinol Metab 291:E358–E364.
   PubMedGoogle Scholar
• Ismail-Beigi F, Craven T, Banerji MA, Basile J, Calles J, Cohen RM, Cuddihy R, Cushman WC, Genuth S, Grimm RH Jr, Hamilton BP, Hoogwerf B, Karl D, Katz L, Krikorian A, O’Connor P, Pop-Busui R, Schubart U, Simmons D, Taylor H, Thomas A, Weiss D, Hramiak I. 2010. Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomised trial. Lancet 376:419–430.
   PubMed Web of Science ®Google Scholar
• Isomaa B, Almgren P, Tuomi T, Forsén B, Lahti K, Nissén M, Taskinen MR, Groop L. 2001. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 24:683–689.
   PubMed Web of Science ®Google Scholar
• Jiang G, Li Z, Liu F, Ellsworth K, Dallas-Yang Q, Wu M, Ronan J, Esau C, Murphy C, Szalkowski D, Bergeron R, Doebber T, Zhang BB. 2005. Prevention of obesity in mice by antisense oligonucleotide inhibitors of stearoyl-CoA desaturase-1. J Clin Invest 115:1030–1038.
   PubMed Web of Science ®Google Scholar
• Kamagate A, Qu S, Perdomo G, Su D, Kim DH, Slusher S, Meseck M, Dong HH. 2008. FoxO1 mediates insulin-dependent regulation of hepatic VLDL production in mice. J Clin Invest 118:2347–2364.
   Google Scholar
• Kawaguchi T, Takenoshita M, Kabashima T, Uyeda K. 2001. Glucose and cAMP regulate the L-type pyruvate kinase gene by phosphorylation/dephosphorylation of the carbohydrate response element binding protein. Proc Natl Acad Sci USA 98:13710–13715.
   PubMed Web of Science ®Google Scholar
• Kerouz NJ, Hörsch D, Pons S, Kahn CR. 1997. Differential regulation of insulin receptor substrates-1 and -2 (IRS-1 and IRS-2) and phosphatidylinositol 3-kinase isoforms in liver and muscle of the obese diabetic (ob/ob) mouse. J Clin Invest 100:3164–3172.
   PubMedGoogle Scholar
• Khamzina L, Veilleux A, Bergeron S, Marette A. 2005. Increased activation of the mammalian target of rapamycin pathway in liver and skeletal muscle of obese rats: possible involvement in obesity-linked insulin resistance. Endocrinology 146:1473–1481.
   PubMed Web of Science ®Google Scholar
• Koo SH, Dutcher AK, Towle HC. 2001. Glucose and insulin function through two distinct transcription factors to stimulate expression of lipogenic enzyme genes in liver. J Biol Chem 276:9437–9445.
   PubMedGoogle Scholar
• Koo SH, Towle HC. 2000. Glucose regulation of mouse S(14) gene expression in hepatocytes. Involvement of a novel transcription factor complex. J Biol Chem 275:5200–5207.
   PubMedGoogle Scholar
• Kubota N, Kubota T, Itoh S, Kumagai H, Kozono H, Takamoto I, Mineyama T, Ogata H, Tokuyama K, Ohsugi M, Sasako T, Moroi M, Sugi K, Kakuta S, Iwakura Y, Noda T, Ohnishi S, Nagai R, Tobe K, Terauchi Y, Ueki K, Kadowaki T. 2008. Dynamic functional relay between insulin receptor substrate 1 and 2 in hepatic insulin signaling during fasting and feeding. Cell Metab 8:49–64.
   PubMed Web of Science ®Google Scholar
• Kuriyama H, Liang G, Engelking LJ, Horton JD, Goldstein JL, Brown MS. 2005. Compensatory increase in fatty acid synthesis in adipose tissue of mice with conditional deficiency of SCAP in liver. Cell Metab 1:41–51.
   Google Scholar
• Le Bacquer O, Petroulakis E, Paglialunga S, Poulin F, Richard D, Cianflone K, Sonenberg N. 2007. Elevated sensitivity to diet-induced obesity and insulin resistance in mice lacking 4E-BP1 and 4E-BP2. J Clin Invest 117:387–396.
   PubMed Web of Science ®Google Scholar
• Leavens KF, Easton RM, Shulman GI, Previs SF, Birnbaum MJ. 2009. Akt2 is required for hepatic lipid accumulation in models of insulin resistance. Cell Metab 10:405–418.
   PubMed Web of Science ®Google Scholar
• Lee WN, Bassilian S, Lim S, Boros LG. 2000. Loss of regulation of lipogenesis in the Zucker diabetic (ZDF) rat. Am J Physiol Endocrinol Metab 279:E425–E432.
   PubMed Web of Science ®Google Scholar
• Lelliott CJ, Medina-Gomez G, Petrovic N, Kis A, Feldmann HM, Bjursell M, Parker N, Curtis K, Campbell M, Hu P, Zhang D, Litwin SE, Zaha VG, Fountain KT, Boudina S, Jimenez-Linan M, Blount M, Lopez M, Meirhaeghe A, Bohlooly-Y M, Storlien L, Strömstedt M, Snaith M, Oresic M, Abel ED, Cannon B, Vidal-Puig A. 2006. Ablation of PGC-1beta results in defective mitochondrial activity, thermogenesis, hepatic function, and cardiac performance. PLoS Biol 4:e369.
   PubMedGoogle Scholar
• Leone TC, Lehman JJ, Finck BN, Schaeffer PJ, Wende AR, Boudina S, Courtois M, Wozniak DF, Sambandam N, Bernal-Mizrachi C, Chen Z, Holloszy JO, Medeiros DM, Schmidt RE, Saffitz JE, Abel ED, Semenkovich CF, Kelly DP. 2005. PGC-1alpha deficiency causes multi-system energy metabolic derangements: muscle dysfunction, abnormal weight control and hepatic steatosis. PLoS Biol 3:e101.
   PubMed Web of Science ®Google Scholar
• Li S, Brown MS, Goldstein JL. 2010. Bifurcation of insulin signaling pathway in rat liver: mTORC1 required for stimulation of lipogenesis, but not inhibition of gluconeogenesis. Proc Natl Acad Sci USA 107:3441–3446.
   PubMed Web of Science ®Google Scholar
• Li X, Grundy SM, Patel SB. 1997. Obesity in db and ob animals leads to impaired hepatic very low density lipoprotein secretion and differential secretion of apolipoprotein B-48 and B-100. J Lipid Res 38:1277–1288.
   PubMedGoogle Scholar
• Li X, Monks B, Ge Q, Birnbaum MJ. 2007. Akt/PKB regulates hepatic metabolism by directly inhibiting PGC-1alpha transcription coactivator. Nature 447:1012–1016.
   PubMed Web of Science ®Google Scholar
• Liang G, Yang J, Horton JD, Hammer RE, Goldstein JL, Brown MS. 2002. Diminished hepatic response to fasting/refeeding and liver X receptor agonists in mice with selective deficiency of sterol regulatory element-binding protein-1c. J Biol Chem 277:9520–9528.
   PubMed Web of Science ®Google Scholar
• Liao W, Hui TY, Young SG, Davis RA. 2003. Blocking microsomal triglyceride transfer protein interferes with apoB secretion without causing retention or stress in the ER. J Lipid Res 44:978–985.
   PubMed Web of Science ®Google Scholar
• Lin J, Handschin C, Spiegelman BM. 2005. Metabolic control through the PGC-1 family of transcription coactivators. Cell Metab 1:361–370.
   PubMed Web of Science ®Google Scholar
• Luong N, Davies CR, Wessells RJ, Graham SM, King MT, Veech R, Bodmer R, Oldham SM. 2006. Activated FOXO-mediated insulin resistance is blocked by reduction of TOR activity. Cell Metab 4:133–142.
   PubMed Web of Science ®Google Scholar
• Lusis AJ, Attie AD, Reue K. 2008. Metabolic syndrome: from epidemiology to systems biology. Nat Rev Genet 9:819–830.
   PubMed Web of Science ®Google Scholar
• Mao J, DeMayo FJ, Li H, Abu-Elheiga L, Gu Z, Shaikenov TE, Kordari P, Chirala SS, Heird WC, Wakil SJ. 2006. Liver-specific deletion of acetyl-CoA carboxylase 1 reduces hepatic triglyceride accumulation without affecting glucose homeostasis. Proc Natl Acad Sci USA 103:8552–8557.
   PubMed Web of Science ®Google Scholar
• Matsuda M, Korn BS, Hammer RE, Moon YA, Komuro R, Horton JD, Goldstein JL, Brown MS, Shimomura I. 2001. SREBP cleavage-activating protein (SCAP) is required for increased lipid synthesis in liver induced by cholesterol deprivation and insulin elevation. Genes Dev 15:1206–1216.
   PubMed Web of Science ®Google Scholar
• Matsumoto M, Han S, Kitamura T, Accili D. 2006. Dual role of transcription factor FoxO1 in controlling hepatic insulin sensitivity and lipid metabolism. J Clin Invest 116:2464–2472.
   PubMed Web of Science ®Google Scholar
• Matsumoto M, Ogawa W, Akimoto K, Inoue H, Miyake K, Furukawa K, Hayashi Y, Iguchi H, Matsuki Y, Hiramatsu R, Shimano H, Yamada N, Ohno S, Kasuga M, Noda T. 2003. PKClambda in liver mediates insulin-induced SREBP-1c expression and determines both hepatic lipid content and overall insulin sensitivity. J Clin Invest 112:935–944.
   PubMed Web of Science ®Google Scholar
• McGarry JD. 1992. What if Minkowski had been ageusic? An alternative angle on diabetes. Science 258:766–770.
   PubMed Web of Science ®Google Scholar
• Michael MD, Kulkarni RN, Postic C, Previs SF, Shulman GI, Magnuson MA, Kahn CR. 2000. Loss of insulin signaling in hepatocytes leads to severe insulin resistance and progressive hepatic dysfunction. Mol Cell 6:87–97.
   PubMed Web of Science ®Google Scholar
• Miyake K, Ogawa W, Matsumoto M, Nakamura T, Sakaue H, Kasuga M. 2002. Hyperinsulinemia, glucose intolerance, and dyslipidemia induced by acute inhibition of phosphoinositide 3-kinase signaling in the liver. J Clin Invest 110:1483–1491.
   PubMedGoogle Scholar
• Miyazaki M, Flowers MT, Sampath H, Chu K, Otzelberger C, Liu X, Ntambi JM. 2007. Hepatic stearoyl-CoA desaturase-1 deficiency protects mice from carbohydrate-induced adiposity and hepatic steatosis. Cell Metab 6:484–496.
   PubMed Web of Science ®Google Scholar
• Neschen S, Morino K, Hammond LE, Zhang D, Liu ZX, Romanelli AJ, Cline GW, Pongratz RL, Zhang XM, Choi CS, Coleman RA, Shulman GI. 2005. Prevention of hepatic steatosis and hepatic insulin resistance in mitochondrial acyl-CoA:glycerol-sn-3-phosphate acyltransferase 1 knockout mice. Cell Metab 2:55–65.
   PubMed Web of Science ®Google Scholar
• Ntambi JM, Miyazaki M, Stoehr JP, Lan H, Kendziorski CM, Yandell BS, Song Y, Cohen P, Friedman JM, Attie AD. 2002. Loss of stearoyl-CoA desaturase-1 function protects mice against adiposity. Proc Natl Acad Sci USA 99:11482–11486.
   PubMed Web of Science ®Google Scholar
• Ono H, Shimano H, Katagiri H, Yahagi N, Sakoda H, Onishi Y, Anai M, Ogihara T, Fujishiro M, Viana AY, Fukushima Y, Abe M, Shojima N, Kikuchi M, Yamada N, Oka Y, Asano T. 2003. Hepatic Akt activation induces marked hypoglycemia, hepatomegaly, and hypertriglyceridemia with sterol regulatory element binding protein involvement. Diabetes 52:2905–2913.
   PubMed Web of Science ®Google Scholar
• Parekh S, Anania FA. 2007. Abnormal lipid and glucose metabolism in obesity: implications for nonalcoholic fatty liver disease. Gastroenterology 132:2191–2207.
   PubMed Web of Science ®Google Scholar
• Pende M, Kozma SC, Jaquet M, Oorschot V, Burcelin R, Le Marchand-Brustel Y, Klumperman J, Thorens B, Thomas G. 2000. Hypoinsulinaemia, glucose intolerance and diminished beta-cell size in S6K1-deficient mice. Nature 408:994–997.
   PubMed Web of Science ®Google Scholar
• Pocai A, Obici S, Schwartz GJ, Rossetti L. 2005. A brain-liver circuit regulates glucose homeostasis. Cell Metab 1:53–61.
   PubMed Web of Science ®Google Scholar
• Porstmann T, Griffiths B, Chung YL, Delpuech O, Griffiths JR, Downward J, Schulze A. 2005. PKB/Akt induces transcription of enzymes involved in cholesterol and fatty acid biosynthesis via activation of SREBP. Oncogene 24:6465–6481.
   PubMed Web of Science ®Google Scholar
• Porstmann T, Santos CR, Griffiths B, Cully M, Wu M, Leevers S, Griffiths JR, Chung YL, Schulze A. 2008. SREBP activity is regulated by mTORC1 and contributes to Akt-dependent cell growth. Cell Metab 8:224–236.
   PubMed Web of Science ®Google Scholar
• Postic C, Dentin R, Denechaud PD, Girard J. 2007. ChREBP, a transcriptional regulator of glucose and lipid metabolism. Annu Rev Nutr 27:179–192.
   PubMedGoogle Scholar
• Postic C, Girard J. 2008a. Contribution of de novo fatty acid synthesis to hepatic steatosis and insulin resistance: lessons from genetically engineered mice. J Clin Invest 118:829–838.
   PubMed Web of Science ®Google Scholar
• Postic C, Girard J. 2008b. The role of the lipogenic pathway in the development of hepatic steatosis. Diabetes Metab 34:643–648.
   PubMed Web of Science ®Google Scholar
• Punga T, Bengoechea-Alonso MT, Ericsson J. 2006. Phosphorylation and ubiquitination of the transcription factor sterol regulatory element-binding protein-1 in response to DNA binding. J Biol Chem 281:25278–25286.
   Google Scholar
• Reilly MP, Rader DJ. 2003. The metabolic syndrome: more than the sum of its parts? Circulation 108:1546–1551.
   PubMed Web of Science ®Google Scholar
• Ribaux PG, Iynedjian PB. 2003. Analysis of the role of protein kinase B (cAKT) in insulin-dependent induction of glucokinase and sterol regulatory element-binding protein 1 (SREBP1) mRNAs in hepatocytes. Biochem J 376:697–705.
   PubMed Web of Science ®Google Scholar
• Roach PJ. 2002. Glycogen and its metabolism. Curr Mol Med 2:101–120.
   PubMedGoogle Scholar
• Sajan MP, Standaert ML, Nimal S, Varanasi U, Pastoor T, Mastorides S, Braun U, Leitges M, Farese RV. 2009. The critical role of atypical protein kinase C in activating hepatic SREBP-1c and NFkappaB in obesity. J Lipid Res 50:1133–1145.
   PubMedGoogle Scholar
• Saltiel AR. 2001. New perspectives into the molecular pathogenesis and treatment of type 2 diabetes. Cell 104:517–529.
   PubMed Web of Science ®Google Scholar
• Sarbassov DD, Guertin DA, Ali SM, Sabatini DM. 2005. Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex. Science 307:1098–1101.
   PubMed Web of Science ®Google Scholar
• Satapati S, He T, Inagaki T, Potthoff M, Merritt ME, Esser V, Mangelsdorf DJ, Kliewer SA, Browning JD, Burgess SC. 2008. Partial resistance to peroxisome proliferator-activated receptor-alpha agonists in ZDF rats is associated with defective hepatic mitochondrial metabolism. Diabetes 57:2012–2021.
   Google Scholar
• Savage DB, Choi CS, Samuel VT, Liu ZX, Zhang D, Wang A, Zhang XM, Cline GW, Yu XX, Geisler JG, Bhanot S, Monia BP, Shulman GI. 2006. Reversal of diet-induced hepatic steatosis and hepatic insulin resistance by antisense oligonucleotide inhibitors of acetyl-CoA carboxylases 1 and 2. J Clin Invest 116:817–824.
   PubMed Web of Science ®Google Scholar
• Schwarz JM, Linfoot P, Dare D, Aghajanian K. 2003. Hepatic de novo lipogenesis in normoinsulinemic and hyperinsulinemic subjects consuming high-fat, low-carbohydrate and low-fat, high-carbohydrate isoenergetic diets. Am J Clin Nutr 77:43–50.
   PubMed Web of Science ®Google Scholar
• Schwarz JM, Neese RA, Turner S, Dare D, Hellerstein MK. 1995. Short-term alterations in carbohydrate energy intake in humans. Striking effects on hepatic glucose production, de novo lipogenesis, lipolysis, and whole-body fuel selection. J Clin Invest 96:2735–2743.
   PubMedGoogle Scholar
• Sengupta S, Peterson TR, Sabatini DM. 2010. Regulation of the mTOR complex 1 pathway by nutrients, growth factors, and stress. Mol Cell 40:310–322.
   PubMed Web of Science ®Google Scholar
• Shimano H, Horton JD, Hammer RE, Shimomura I, Brown MS, Goldstein JL. 1996. Overproduction of cholesterol and fatty acids causes massive liver enlargement in transgenic mice expressing truncated SREBP-1a. J Clin Invest 98:1575–1584.
   PubMed Web of Science ®Google Scholar
• Shimano H, Horton JD, Shimomura I, Hammer RE, Brown MS, Goldstein JL. 1997a. Isoform 1c of sterol regulatory element binding protein is less active than isoform 1a in livers of transgenic mice and in cultured cells. J Clin Invest 99:846–854.
   PubMed Web of Science ®Google Scholar
• Shimano H, Shimomura I, Hammer RE, Herz J, Goldstein JL, Brown MS, Horton JD. 1997b. Elevated levels of SREBP-2 and cholesterol synthesis in livers of mice homozygous for a targeted disruption of the SREBP-1 gene. J Clin Invest 100:2115–2124.
   PubMed Web of Science ®Google Scholar
• Shimano H, Yahagi N, Amemiya-Kudo M, Hasty AH, Osuga J, Tamura Y, Shionoiri F, Iizuka Y, Ohashi K, Harada K, Gotoda T, Ishibashi S, Yamada N. 1999. Sterol regulatory element-binding protein-1 as a key transcription factor for nutritional induction of lipogenic enzyme genes. J Biol Chem 274:35832–35839.
   PubMed Web of Science ®Google Scholar
• Shimomura I, Bashmakov Y, Horton JD. 1999a. Increased levels of nuclear SREBP-1c associated with fatty livers in two mouse models of diabetes mellitus. J Biol Chem 274:30028–30032.
   PubMed Web of Science ®Google Scholar
• Shimomura I, Bashmakov Y, Ikemoto S, Horton JD, Brown MS, Goldstein JL. 1999b. Insulin selectively increases SREBP-1c mRNA in the livers of rats with streptozotocin-induced diabetes. Proc Natl Acad Sci USA 96:13656–13661.
   PubMed Web of Science ®Google Scholar
• Shimomura I, Shimano H, Horton JD, Goldstein JL, Brown MS. 1997. Differential expression of exons 1a and 1c in mRNAs for sterol regulatory element binding protein-1 in human and mouse organs and cultured cells. J Clin Invest 99:838–845.
   PubMed Web of Science ®Google Scholar
• Shimomura I, Shimano H, Korn BS, Bashmakov Y, Horton JD. 1998. Nuclear sterol regulatory element-binding proteins activate genes responsible for the entire program of unsaturated fatty acid biosynthesis in transgenic mouse liver. J Biol Chem 273:35299–35306.
   PubMed Web of Science ®Google Scholar
• Simmgen M, Knauf C, Lopez M, Choudhury AI, Charalambous M, Cantley J, Bedford DC, Claret M, Iglesias MA, Heffron H, Cani PD, Vidal-Puig A, Burcelin R, Withers DJ. 2006. Liver-specific deletion of insulin receptor substrate 2 does not impair hepatic glucose and lipid metabolism in mice. Diabetologia 49:552–561.
   PubMed Web of Science ®Google Scholar
• Sonoda J, Mehl IR, Chong LW, Nofsinger RR, Evans RM. 2007. PGC-1beta controls mitochondrial metabolism to modulate circadian activity, adaptive thermogenesis, and hepatic steatosis. Proc Natl Acad Sci USA 104:5223–5228.
   PubMed Web of Science ®Google Scholar
• Sparks JD, Sparks CE. 1994. Insulin regulation of triacylglycerol-rich lipoprotein synthesis and secretion. Biochim Biophys Acta 1215:9–32.
   PubMedGoogle Scholar
• Sparks JD, Sparks CE, Miller LL. 1989. Insulin effects on apolipoprotein B production by normal, diabetic and treated-diabetic rat liver and cultured rat hepatocytes. Biochem J 261:83–88.
   Google Scholar
• Stephens L, Anderson K, Stokoe D, Erdjument-Bromage H, Painter GF, Holmes AB, Gaffney PR, Reese CB, McCormick F, Tempst P, Coadwell J, Hawkins PT. 1998. Protein kinase B kinases that mediate phosphatidylinositol 3,4,5-trisphosphate-dependent activation of protein kinase B. Science 279:710–714.
   PubMed Web of Science ®Google Scholar
• Stiles B, Wang Y, Stahl A, Bassilian S, Lee WP, Kim YJ, Sherwin R, Devaskar S, Lesche R, Magnuson MA, Wu H. 2004. Liver-specific deletion of negative regulator Pten results in fatty liver and insulin hypersensitivity [corrected]. Proc Natl Acad Sci USA 101:2082–2087.
   PubMed Web of Science ®Google Scholar
• Stoeckman AK, Towle HC. 2002. The role of SREBP-1c in nutritional regulation of lipogenic enzyme gene expression. J Biol Chem 277:27029–27035.
   Google Scholar
• Sundqvist A, Bengoechea-Alonso MT, Ye X, Lukiyanchuk V, Jin J, Harper JW, Ericsson J. 2005. Control of lipid metabolism by phosphorylation-dependent degradation of the SREBP family of transcription factors by SCF(Fbw7). Cell Metab 1:379–391.
   PubMed Web of Science ®Google Scholar
• Taghibiglou C, Carpentier A, Van Iderstine SC, Chen B, Rudy D, Aiton A, Lewis GF, Adeli K. 2000. Mechanisms of hepatic very low density lipoprotein overproduction in insulin resistance. Evidence for enhanced lipoprotein assembly, reduced intracellular apoB degradation, and increased microsomal triglyceride transfer protein in a fructose-fed hamster model. J Biol Chem 275:8416–8425.
   PubMed Web of Science ®Google Scholar
• Tamemoto H, Kadowaki T, Tobe K, Yagi T, Sakura H, Hayakawa T, Terauchi Y, Ueki K, Kaburagi Y, Satoh S. 1994. Insulin resistance and growth retardation in mice lacking insulin receptor substrate-1. Nature 372:182–186.
   PubMed Web of Science ®Google Scholar
• Taniguchi CM, Emanuelli B, Kahn CR. 2006a. Critical nodes in signalling pathways: insights into insulin action. Nat Rev Mol Cell Biol 7:85–96.
   PubMed Web of Science ®Google Scholar
• Taniguchi CM, Kondo T, Sajan M, Luo J, Bronson R, Asano T, Farese R, Cantley LC, Kahn CR. 2006b. Divergent regulation of hepatic glucose and lipid metabolism by phosphoinositide 3-kinase via Akt and PKClambda/zeta. Cell Metab 3:343–353.
   PubMed Web of Science ®Google Scholar
• Taniguchi CM, Ueki K, Kahn R. 2005. Complementary roles of IRS-1 and IRS-2 in the hepatic regulation of metabolism. J Clin Invest 115:718–727.
   PubMed Web of Science ®Google Scholar
• Taskinen MR. 2003. Diabetic dyslipidaemia: from basic research to clinical practice. Diabetologia 46:733–749.
   PubMed Web of Science ®Google Scholar
• Teleman AA, Chen YW, Cohen SM. 2005. 4E-BP functions as a metabolic brake used under stress conditions but not during normal growth. Genes Dev 19:1844–1848.
   PubMed Web of Science ®Google Scholar
• Timlin MT, Parks EJ. 2005. Temporal pattern of de novo lipogenesis in the postprandial state in healthy men. Am J Clin Nutr 81:35–42.
   PubMed Web of Science ®Google Scholar
• Tobe K, Suzuki R, Aoyama M, Yamauchi T, Kamon J, Kubota N, Terauchi Y, Matsui J, Akanuma Y, Kimura S, Tanaka J, Abe M, Ohsumi J, Nagai R, Kadowaki T. 2001. Increased expression of the sterol regulatory element-binding protein-1 gene in insulin receptor substrate-2(-/-) mouse liver. J Biol Chem 276:38337–38340.
   PubMed Web of Science ®Google Scholar
• Um SH, Frigerio F, Watanabe M, Picard F, Joaquin M, Sticker M, Fumagalli S, Allegrini PR, Kozma SC, Auwerx J, Thomas G. 2004. Absence of S6K1 protects against age- and diet-induced obesity while enhancing insulin sensitivity. Nature 431:200–205.
   PubMed Web of Science ®Google Scholar
• WHO 2008. Fact Sheet: The Top Ten Causes of Death. In: World Health Organization, M. C. (ed.) http://www.who.int/mediacentre/factsheets/fs310/en/index.html.
   Google Scholar
• Wiegman CH, Bandsma RH, Ouwens M, van der Sluijs FH, Havinga R, Boer T, Reijngoud DJ, Romijn JA, Kuipers F. 2003. Hepatic VLDL production in ob/ob mice is not stimulated by massive de novo lipogenesis but is less sensitive to the suppressive effects of insulin. Diabetes 52:1081–1089.
   PubMedGoogle Scholar
• Withers DJ, Gutierrez JS, Towery H, Burks DJ, Ren JM, Previs S, Zhang Y, Bernal D, Pons S, Shulman GI, Bonner-Weir S, White MF. 1998. Disruption of IRS-2 causes type 2 diabetes in mice. Nature 391:900–904.
   PubMed Web of Science ®Google Scholar
• Wolfrum C, Asilmaz E, Luca E, Friedman JM, Stoffel M. 2004. Foxa2 regulates lipid metabolism and ketogenesis in the liver during fasting and in diabetes. Nature 432:1027–1032.
   PubMed Web of Science ®Google Scholar
• Wolfrum C, Stoffel M. 2006. Coactivation of Foxa2 through Pgc-1beta promotes liver fatty acid oxidation and triglyceride/VLDL secretion. Cell Metab 3:99–110.
   Google Scholar
• Yahagi N, Shimano H, Hasty AH, Matsuzaka T, Ide T, Yoshikawa T, Amemiya-Kudo M, Tomita S, Okazaki H, Tamura Y, Iizuka Y, Ohashi K, Osuga J, Harada K, Gotoda T, Nagai R, Ishibashi S, Yamada N. 2002. Absence of sterol regulatory element-binding protein-1 (SREBP-1) ameliorates fatty livers but not obesity or insulin resistance in Lep(ob)/Lep(ob) mice. J Biol Chem 277:19353–19357.
   PubMed Web of Science ®Google Scholar
• Yamashita H, Takenoshita M, Sakurai M, Bruick RK, Henzel WJ, Shillinglaw W, Arnot D, Uyeda K. 2001. A glucose-responsive transcription factor that regulates carbohydrate metabolism in the liver. Proc Natl Acad Sci USA 98:9116–9121.
   PubMed Web of Science ®Google Scholar
• Yang J, Goldstein JL, Hammer RE, Moon YA, Brown MS, Horton JD. 2001. Decreased lipid synthesis in livers of mice with disrupted Site-1 protease gene. Proc Natl Acad Sci USA 98:13607–13612.
   PubMedGoogle Scholar
• Zhang L, Rubins NE, Ahima RS, Greenbaum LE, Kaestner KH. 2005. Foxa2 integrates the transcriptional response of the hepatocyte to fasting. Cell Metab 2:141–148.
   PubMedGoogle Scholar
• Zhang W, Patil S, Chauhan B, Guo S, Powell DR, Le J, Klotsas A, Matika R, Xiao X, Franks R, Heidenreich KA, Sajan MP, Farese RV, Stolz DB, Tso P, Koo SH, Montminy M, Unterman TG. 2006. FoxO1 regulates multiple metabolic pathways in the liver: effects on gluconeogenic, glycolytic, and lipogenic gene expression. J Biol Chem 281:10105–10117.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Castellani LW, Sinal CJ, Gonzalez FJ, Edwards PA. 2004a. Peroxisome proliferator-activated receptor-gamma coactivator 1alpha (PGC-1alpha) regulates triglyceride metabolism by activation of the nuclear receptor FXR. Genes Dev 18:157–169.
   PubMed Web of Science ®Google Scholar
• Zhang YL, Hernandez-Ono A, Ko C, Yasunaga K, Huang LS, Ginsberg HN. 2004b. Regulation of hepatic apolipoprotein B-lipoprotein assembly and secretion by the availability of fatty acids. I. Differential response to the delivery of fatty acids via albumin or remnant-like emulsion particles. J Biol Chem 279:19362–19374.
   PubMedGoogle Scholar